571 related articles for article (PubMed ID: 19324084)
1. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
[TBL] [Abstract][Full Text] [Related]
2. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
[TBL] [Abstract][Full Text] [Related]
3. Selective interactions of spinophilin with the C-terminal domains of the δ- and μ-opioid receptors and G proteins differentially modulate opioid receptor signaling.
Fourla DD; Papakonstantinou MP; Vrana SM; Georgoussi Z
Cell Signal; 2012 Dec; 24(12):2315-28. PubMed ID: 22922354
[TBL] [Abstract][Full Text] [Related]
4. RGS2 and RGS4 proteins: New modulators of the κ-opioid receptor signaling.
Papakonstantinou MP; Karoussiotis C; Georgoussi Z
Cell Signal; 2015 Jan; 27(1):104-14. PubMed ID: 25289860
[TBL] [Abstract][Full Text] [Related]
5. Expression of the third intracellular loop of the delta-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors.
Morou E; Georgoussi Z
J Pharmacol Exp Ther; 2005 Dec; 315(3):1368-79. PubMed ID: 16160084
[TBL] [Abstract][Full Text] [Related]
6. Multi-component signaling complexes of the delta-opioid receptor with STAT5B and G proteins.
Georganta EM; Agalou A; Georgoussi Z
Neuropharmacology; 2010 Sep; 59(3):139-48. PubMed ID: 20433855
[TBL] [Abstract][Full Text] [Related]
7. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.
Clark MJ; Neubig RR; Traynor JR
J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136
[TBL] [Abstract][Full Text] [Related]
8. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
[TBL] [Abstract][Full Text] [Related]
9. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
10. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
Clark MJ; Traynor JR
Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol-3 kinase is distinctively required for mu-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase.
Kam AY; Chan AS; Wong YH
J Neurochem; 2004 Apr; 89(2):391-402. PubMed ID: 15056283
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
13. Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists.
Hasbi A; Nguyen T; Fan T; Cheng R; Rashid A; Alijaniaram M; Rasenick MM; O'Dowd BF; George SR
Biochemistry; 2007 Nov; 46(45):12997-3009. PubMed ID: 17941650
[TBL] [Abstract][Full Text] [Related]
14. G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.
Tso PH; Wong YH
J Pharmacol Exp Ther; 2000 Oct; 295(1):168-76. PubMed ID: 10991975
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity.
Ghavami A; Hunt RA; Olsen MA; Zhang J; Smith DL; Kalgaonkar S; Rahman Z; Young KH
Cell Signal; 2004 Jun; 16(6):711-21. PubMed ID: 15093612
[TBL] [Abstract][Full Text] [Related]
16. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
17. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
18. Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Ialpha, Galpha(i) proteins, and ERK1/2 signaling.
García-Fuster MJ; Ramos-Miguel A; Miralles A; García-Sevilla JA
Neuropharmacology; 2008 Oct; 55(5):886-99. PubMed ID: 18657552
[TBL] [Abstract][Full Text] [Related]
19. Multi-tasking RGS proteins in the heart: the next therapeutic target?
Riddle EL; Schwartzman RA; Bond M; Insel PA
Circ Res; 2005 Mar; 96(4):401-11. PubMed ID: 15746448
[TBL] [Abstract][Full Text] [Related]
20. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
